Organisation
Surgical Oncology
Division
There are four main topics of research which are closely related to major areas of clinical work. 1. Identifying prognostic and predictive biomarkers in breast cancer patients. 2. Molecular annotation of somatic mutations in sarcoma and the discovery and validation of genetic biomarkers and establishing cell lines and tumor xenografts. 3. Genetic polymorphism in melanoma; vitamin D and malignant melanoma; characterization of tumor response to Melphalan in vivo and relapses. 4. Tissue sampling for various studies: breast, pediatric oncology, sarcoma, skin, hematology
Current researchers
1 - 6 of 6 results
- Daphne Hompes (Responsible)
- Veerle Boecxstaens (Member)
- Daphne Hompes (Member)
- Ines Nevelsteen (Member)
- Ann Smeets (Member)
- Hanne Vos (Member)
Projects
1 - 10 of 16
- iSurvive-Mind Helpt het geheugen van (ex-)kankerpatiëntenFrom1 May 2023 → TodayFunding: Provinces
- The enigma of subjective lymphedema: Why do patients report lymphedema after breast cancer treatment without an objective measurable swelling? The role of sensory processing and subclinical lymphedema – LymphSens TrialFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Impact of adiposity and lifestyle on breast cancer biology and treatment response.From7 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Golden-NK: employing gold-mediated thermal heating for improved and safe immunotherapyFrom1 Oct 2022 → TodayFunding: BOF - projects
- Effectiveness of an eHealth self-management support program for persistent pain after breast cancer treatmentFrom1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Contemporary view and new insights in mid –and long term vascular accessFrom18 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From25 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From1 Oct 2021 → TodayFunding: BOF - projects
- Connecting Single-cell Immune Profiling in Peripheral Blood with Intratumoral T Cell Expansion in Breast Cancer Upon Checkpoint ImmunotherapyFrom24 Aug 2021 → TodayFunding: FWO Strategic Basic Research Grant
- A mindfulness-based intervention as candidate to reduce cognitive impairment and recover brain changes after breast cancer treatment.From2 Jan 2019 → 1 Jan 2024Funding: FWO Strategic Basic Research Grant
Publications
331 - 340 of 382
- The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study(2012)
Authors: Daphne Hompes, Eric Van Cutsem, Steffen Fieuws
Pages: 2186 - 2194 - Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients(2019)
Authors: Jeroen Blommaert, Gwen Schroyen, Mathieu Vandenbulcke, Ahmed Radwan, Ann Smeets, Ronald Peeters, Charlotte Sleurs, Patrick Neven, Hans Wildiers, Frédéric Amant, et al.
Pages: 4994 - 5010 - Veranderingen in hersenvolume en cognitief functioneren na chemotherapie voor borstkanker zijn leeftijdsafhankelijk(2020)
Authors: Jeroen Blommaert, Gwen Schroyen, Mathieu Vandenbulcke, Ahmed Radwan, Ann Smeets, Ronald Peeters, Charlotte Sleurs, Patrick Neven, Hans Wildiers, Frédéric Amant, et al.
Pages: 21 - 24 - Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors(2009)
Authors: Olivier Brouckaert, Saskia Pintens, Vanya Van Belle, Sabine Van Huffel, Edward Camerlynck, Frédéric Amant, Ann Smeets, Karin Leunen, Erik Van Limbergen, Patrick Berteloot, et al.
Pages: 349 - 358 - Clinical trial: a controlled trial of baclofen add-on therapy in PPI-refractory gastro-oesophageal reflux symptoms(2022)
Authors: Karlien Raymenants, Annelies Geeraerts, Veerle Boecxstaens, Tim Vanuytsel, Jan Tack
Pages: 231 - 239 - Utility of p53 Immunostaining in Predicting Multigene Signatures Risk Category Results and Molecular Subtypes in a Series of Estrogen Receptor Positive and HER2 Negative Early Breast Cancers(2020)
Authors: Beppe Floris, Laurence Slembrouck, Mieke Van Bockstal, Laura Gadeyne, Anne-Sophie Van Rompuy, Cecile Colpaert, Sanne Verbeek, Claire Bourgain, Kevin Punie, Hans Wildiers, et al.
Pages: 142 - 144 - Prognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data(2014)
Authors: Annouschka Laenen, Ann Smeets, Rose Christiaens, Ignace Vergote, Hans Wildiers, Philippe Moerman, Beppe Floris, Patrick Neven
Pages: 371 - 377 - The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial(2009)
Authors: Christine Desmedt, Patrick Neven, Robert Paridaens, Rose Christiaens, Ann Smeets
- Utility of p53 Immunostaining in Predicting Multigene Signatures Risk Category Results and Molecular Subtypes in a Series of Estrogen Receptor Positive and HER2 Negative Early Breast Cancers(2020)
Authors: Beppe Floris, Laurence Slembrouck, Mieke Van Bockstal, Laura Gadeyne, Anne-Sophie Van Rompuy, Cecile Colpaert, Sanne Verbeek, Claire Bourgain, Kevin Punie, Hans Wildiers, et al.
Pages: 142 - 144 - Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.(2019)
Authors: Kathleen Lambein, Ann Smeets, Laurence Slembrouck, Patrick Neven, Ines Nevelsteen, Caroline Weltens, Erik Van Limbergen, Rose Christiaens, Chantal Van Ongeval, Hans Wildiers, et al.
Pages: 550 - 559